Sphincter of Oddi Dysfunction Clinical Trial
Official title:
A Phase III Randomized Multicenter Clinical Trial of Sphincterotomy for the Treatment of SOD III Patients
The Evaluating Predictors & Interventions in Sphincter of Oddi Dysfunction(SOD) study (EPISOD) is a randomized sham-controlled study of biliary and pancreatic sphincterotomy as treatment for patients with pain after cholecystectomy fitting the criteria for sphincter of Oddi dysfunction type III.
Clinical Trial Phase: Phase III
Study Sites Seven clinical centers in US
Study Period Planned enrollment period - 3 years
Planned duration of the study - 5 years
Study Population SOD III Patients
Primary Study Objective: To ascertain whether subjects with SOD III respond to
sphincterotomy,
Secondary Study Objectives
To evaluate:
- the association between the results of Sphincter of Oddi Manometry (SOM)
(abnormal/normal) and the primary outcome (success/failure);
- the success rate (as defined in the primary) of subjects who receive biliary
sphincterotomy alone versus subjects who receive both biliary and pancreatic
sphincterotomy in the subgroup of patients with manometrically proven hypertension of
the pancreatic sphincter;
- the effects of pre-specified prognostic factors on the primary outcome;
- anxiety and depression scores over time and their relation to study outcomes;
- the economic impact of SOD III, and of endoscopic sphincterotomy in patients with SOD
III; and, to,
- conduct a careful follow-up study (EPISOD2) of standard of care treatment (separate
protocol).
Study Design The EPISOD Trial is a parallel, randomized, double-blinded, sham-controlled,
multicenter Phase III clinical trial of endoscopic sphincterotomy as treatment for adults 18
to 65 years of age diagnosed with SOD III.
Sample Size A minimum of 214 subjects will be randomized using a 2:1 allocation in favor of
sphincterotomy and will be followed for 12 months post-randomization.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01410071 -
Evaluation of Gastrointestinal Symptoms and Quality of Life in Patients With Sphincter of Oddi Dysfunction
|
N/A | |
Completed |
NCT02916199 -
Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method
|
N/A | |
Recruiting |
NCT02833103 -
Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction
|
Phase 4 | |
Completed |
NCT00471315 -
Duloxetine in Patients With Suspected Functional Pancreatic/Biliary Pain (Sphincter of Oddi Dysfunction)
|
Phase 3 | |
Completed |
NCT01134848 -
A Study of Serial Magnetic Resonance Cholangiopancreatography (MRCP) Following Morphine-neostigmine and Secretin Provocation in Healthy Volunteers
|
Phase 4 | |
Recruiting |
NCT03977779 -
Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis
|
N/A | |
Recruiting |
NCT03999333 -
Virtual Reality in SOD
|
N/A | |
Not yet recruiting |
NCT06315179 -
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
|